Latest SenzaGen News & Updates

See the latest news and media coverage for SenzaGen. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
SenzaGen

In vitro skin sensitization testing laboratory

senzagen.com
Headquarters
Lund, Sweden
Founded year
2010
Company type
Public company
Number of employees
20–50

Latest news about SenzaGen

Company announcements

  • SenzaGen

    SenzaGen publishes its 2025 Annual Report

    A digital copy is available for download at www.senzagen.com. Printed copies can be requested via IR@senzagen.com.

  • SenzaGen

    SenzaGen issues notice of annual general meeting

    The AGM is scheduled for 12 May 2026 at 2 PM in Lund, Sweden. It includes approval of financial statements, board elections, remuneration policies, and share issuance authorization.

  • SenzaGen

    SenzaGen announces GARD®air presentations by NICEATM and Merck

    At the Society of Toxicology conference, they present independent evaluations of the non-animal respiratory allergy test. A new European patent strengthens IP protection. CEO highlights growth potential.

  • SenzaGen

    SenzaGen carries out directed issue of SEK 17.5 million

    The Board resolves to issue 3,004,021 shares at SEK 5.82 to Eiffel Investment Group. Proceeds strengthen commercial capacity, project management, and testing portfolio.

Unlock all announcements with a

Media coverage

  • FinanzNachrichten

    SenzaGen AB: SenzaGen's subsidiary receives strategically important order

    SenzaGens's subsidiary VitroScreen has received an order from an existing customer for non-animal efficacy testing. The order includes studies using the proprietary platform VitroScreenORA® and...

  • MarketWatch

    SenzaGen AB

    SenzaGen AB Annual cash flow by MarketWatch. View 26S net cash flow, operating cash flow, operating expenses and cash dividends.

  • MFN

    SenzaGen presents strong GARD®skin-data at the world's largest t...

    SenzaGen, which develops and sells advanced animal-free test methods based on genomics and machine learning, continues to solidify its position as a thought leader within animal-free test methods. The...

  • FinanzNachrichten

    SenzaGen AB: SenzaGen carries out a directed issue of approximately SEK 17.5 million to the institutional investor Eiffel Investment Group

    THIS PRESS RELEASE MAY NOT BE ANNOUNCED, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA...

Unlock all articles with a

Never miss news about SenzaGen

Track SenzaGen and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.